61 related articles for article (PubMed ID: 31988090)
1. Unveiling the role of PYGB in pancreatic cancer: a novel diagnostic biomarker and gene therapy target.
Ren LK; Lu RS; Fei XB; Chen SJ; Liu P; Zhu CH; Wang X; Pan YZ
J Cancer Res Clin Oncol; 2024 Mar; 150(3):127. PubMed ID: 38483604
[TBL] [Abstract][Full Text] [Related]
2. FAM172A affects cell proliferation and apoptosis not by targeting β-tubulin in HepG2 cells.
Xu AM; He CJ; Tuerxun Z; Anikezi A
Transl Cancer Res; 2020 Sep; 9(9):5637-5644. PubMed ID: 35117927
[TBL] [Abstract][Full Text] [Related]
3. Fundamental insights and molecular interactions in pancreatic cancer: Pathways to therapeutic approaches.
Gu M; Liu Y; Xin P; Guo W; Zhao Z; Yang X; Ma R; Jiao T; Zheng W
Cancer Lett; 2024 Apr; 588():216738. PubMed ID: 38401887
[TBL] [Abstract][Full Text] [Related]
4. FAM172A Deletion May Enhance Hepatic Steatosis by Promoting ER Stress.
Xiao F; Gao M; Yang J; He L; Wei H
Dig Dis Sci; 2021 Sep; 66(9):3054-3061. PubMed ID: 32945983
[TBL] [Abstract][Full Text] [Related]
5. FAM172A promotes follicular thyroid carcinogenesis and may be a marker of FTC.
Xu PP; Zeng S; Xia XT; Ye ZH; Li MF; Chen MY; Xia T; Xu JJ; Jiao Q; Liu L; Li LX; Guo MG
Endocr Relat Cancer; 2020 Nov; 27(11):657-669. PubMed ID: 33095186
[TBL] [Abstract][Full Text] [Related]
6. Molecular signature to predict quality of life and survival with glioblastoma using Multiview omics model.
Nassani R; Bokhari Y; Alrfaei BM
PLoS One; 2023; 18(11):e0287448. PubMed ID: 37972206
[TBL] [Abstract][Full Text] [Related]
7. Protein Z modulates the metastasis of lung adenocarcinoma cells.
Peng J; Yang KY; Li H; Zheng SS; Pan XY
Open Life Sci; 2023; 18(1):20220667. PubMed ID: 37528887
[TBL] [Abstract][Full Text] [Related]
8. Molecular profile of metastasis, cell plasticity and EMT in pancreatic cancer: a pre-clinical connection to aggressiveness and drug resistance.
Guo Z; Ashrafizadeh M; Zhang W; Zou R; Sethi G; Zhang X
Cancer Metastasis Rev; 2024 Mar; 43(1):29-53. PubMed ID: 37453022
[TBL] [Abstract][Full Text] [Related]
9. m
Liu W; Zhang Z; Luo X; Qian K; Huang B; Liang J; Ma Z; Deng J; Yang C
Int J Oncol; 2023 Jul; 63(1):. PubMed ID: 37264959
[TBL] [Abstract][Full Text] [Related]
10. Whole-genome sequencing of extrachromosomal circular DNA of cerebrospinal fluid of medulloblastoma.
Zhu Y; Liu Z; Guo Y; Li S; Qu Y; Dai L; Chen Y; Ning W; Zhang H; Ma L
Front Oncol; 2022; 12():934159. PubMed ID: 36452490
[TBL] [Abstract][Full Text] [Related]
11. Quantitative Proteomics Explore the Potential Targets and Action Mechanisms of Hydroxychloroquine.
Zhao J; Zhao Z; Hou W; Jiang Y; Liu G; Ren X; Liu K; Liu H; Chen K; Huang H
Molecules; 2022 Aug; 27(16):. PubMed ID: 36014414
[TBL] [Abstract][Full Text] [Related]
12. Sensitization of Non-Small Cell Lung Cancer Cells to Gefitinib and Reversal of Epithelial-Mesenchymal Transition by Aloe-Emodin
Peng M; Zheng Z; Chen S; Fang L; Feng R; Zhang L; Tang Q; Liu X
Front Oncol; 2022; 12():908031. PubMed ID: 35677158
[TBL] [Abstract][Full Text] [Related]
13. FAM126A interacted with ENO1 mediates proliferation and metastasis in pancreatic cancer via PI3K/AKT signaling pathway.
Li Y; Li Y; Luo J; Fu X; Liu P; Liu S; Pan Y
Cell Death Discov; 2022 May; 8(1):248. PubMed ID: 35513377
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic Status and Available Strategies in Pancreatic Ductal Adenocarcinoma.
Thakur G; Kumar R; Kim SB; Lee SY; Lee SL; Rho GJ
Biomedicines; 2021 Feb; 9(2):. PubMed ID: 33670230
[TBL] [Abstract][Full Text] [Related]
15. FAM172A inhibits EMT in pancreatic cancer via ERK-MAPK signaling.
Chen Y; Liu P; Shen D; Liu H; Xu L; Wang J; Shen D; Sun H; Wu H
Biol Open; 2020 Feb; 9(2):. PubMed ID: 31988090
[TBL] [Abstract][Full Text] [Related]
16. The involvement of FBP1 in prostate cancer cell epithelial mesenchymal transition, invasion and metastasis by regulating the MAPK signaling pathway.
Zhang YP; Liu KL; Yang Z; Lu BS; Qi JC; Han ZW; Yin YW; Zhang M; Chen DM; Wang XW; Li W; Xin H
Cell Cycle; 2019 Oct; 18(19):2432-2446. PubMed ID: 31448674
[TBL] [Abstract][Full Text] [Related]
17. Calreticulin promotes EGF-induced EMT in pancreatic cancer cells via Integrin/EGFR-ERK/MAPK signaling pathway.
Sheng W; Chen C; Dong M; Wang G; Zhou J; Song H; Li Y; Zhang J; Ding S
Cell Death Dis; 2017 Oct; 8(10):e3147. PubMed ID: 29072694
[TBL] [Abstract][Full Text] [Related]
18. Calreticulin promotes EMT in pancreatic cancer via mediating Ca
Sheng W; Wang G; Tang J; Shi X; Cao R; Sun J; Lin YH; Jia C; Chen C; Zhou J; Dong M
J Exp Clin Cancer Res; 2020 Oct; 39(1):209. PubMed ID: 33028359
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
